Pharmaceutical Investing AbbVie to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
Pharmaceutical Investing RINVOQ® Receives Health Canada Notice of Compliance for Giant Cell Arteritis in adults
Pharmaceutical Investing AbbVie to Acquire Gilgamesh Pharmaceuticals' Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline
Pharmaceutical Investing AbbVie Announces Positive Topline Results from Second Phase 3 UP-AA Trial Evaluating Upadacitinib for Alopecia Areata
Pharmaceutical Investing AbbVie Announces $195 Million Investment to Expand Active Pharmaceutical Ingredient Manufacturing in the U.S.
Stallion Uranium Completes Second and Final Tranche of Oversubscribed $15,000,000 Non-Brokered Private Placement
